Published in Int J Cell Biol on October 26, 2013
Neurodegenerative diseases: expanding the prion concept. Annu Rev Neurosci (2015) 1.24
Distinct Prion Domain Sequences Ensure Efficient Amyloid Propagation by Promoting Chaperone Binding or Processing In Vivo. PLoS Genet (2016) 0.75
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30
Novel proteinaceous infectious particles cause scrapie. Science (1982) 24.09
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A (1993) 10.36
Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med (1998) 9.01
Synthetic mammalian prions. Science (2004) 7.35
Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol (1997) 7.27
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc Natl Acad Sci U S A (2009) 6.87
Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science (1996) 6.71
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet (2002) 6.56
From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci (2001) 6.48
Generating a prion with bacterially expressed recombinant prion protein. Science (2010) 6.26
Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature (2001) 6.20
Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A (2007) 5.94
Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem (2009) 5.76
The most infectious prion protein particles. Nature (2005) 5.37
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature (2011) 5.27
Cells release prions in association with exosomes. Proc Natl Acad Sci U S A (2004) 5.17
Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol (1994) 5.12
The physical basis of how prion conformations determine strain phenotypes. Nature (2006) 4.77
Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron (2011) 4.74
Paired helical filaments in electron microscopy of Alzheimer's disease. Nature (1963) 4.62
The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem (1991) 4.23
Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci (2005) 3.93
An analytical solution to the kinetics of breakable filament assembly. Science (2009) 3.87
Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci U S A (2000) 3.82
Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci (2010) 3.81
Amyloid fibers are water-filled nanotubes. Proc Natl Acad Sci U S A (2002) 3.78
Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci (2005) 3.69
Regional mapping of prion proteins in brain. Proc Natl Acad Sci U S A (1992) 3.68
Prions hijack tunnelling nanotubes for intercellular spread. Nat Cell Biol (2009) 3.55
Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol (2009) 3.55
Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A (2009) 3.47
Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol (1990) 3.46
Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol (1988) 3.37
Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat Med (2002) 3.31
Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci U S A (2011) 3.23
Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci (2007) 3.16
Polarised asymmetric inheritance of accumulated protein damage in higher eukaryotes. PLoS Biol (2006) 3.06
Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell (2002) 2.98
Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. Genes Dev (1992) 2.87
Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles. J Biol Chem (2011) 2.86
Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains. Proc Natl Acad Sci U S A (1996) 2.79
Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature (2001) 2.78
The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci (2013) 2.78
Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem (1992) 2.67
Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem (2010) 2.67
Physiology of the prion protein. Physiol Rev (2008) 2.65
Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. J Cell Sci (2008) 2.55
Lessons from animal models of Huntington's disease. Trends Genet (2002) 2.54
Transfer of scrapie prion infectivity by cell contact in culture. Curr Biol (2002) 2.54
Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J Biol Chem (1997) 2.48
Trans-cellular propagation of Tau aggregation by fibrillar species. J Biol Chem (2012) 2.42
Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J Cell Biol (1990) 2.42
Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet (1998) 2.39
Cultured cell sublines highly susceptible to prion infection. J Virol (2000) 2.38
Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry (2002) 2.36
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission. Neurobiol Dis (2011) 2.32
A hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis. J Virol (1997) 2.32
Packaging of prions into exosomes is associated with a novel pathway of PrP processing. J Pathol (2007) 2.31
α-Synuclein in central nervous system and from erythrocytes, mammalian cells, and Escherichia coli exists predominantly as disordered monomer. J Biol Chem (2012) 2.31
Prion strain discrimination in cell culture: the cell panel assay. Proc Natl Acad Sci U S A (2007) 2.30
Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease. Hum Mol Genet (2001) 2.29
Mechanism of prion loss after Hsp104 inactivation in yeast. Mol Cell Biol (2001) 2.27
Successful transmission of three mouse-adapted scrapie strains to murine neuroblastoma cell lines overexpressing wild-type mouse prion protein. J Virol (2000) 2.18
Ultrastructural localization of scrapie prion proteins in cytoplasmic vesicles of infected cultured cells. Lab Invest (1991) 2.13
The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci (2010) 2.10
Structural and functional characterization of two alpha-synuclein strains. Nat Commun (2013) 2.05
Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun (2011) 2.04
Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J Virol (1988) 1.92
Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases. J Biol Chem (2010) 1.92
Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc Natl Acad Sci U S A (2011) 1.82
Stochastic kinetics of intracellular huntingtin aggregate formation. Nat Chem Biol (2006) 1.81
Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J Biol Chem (2005) 1.79
Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons. J Biol Chem (2012) 1.79
Post-translational modifications of tau protein in Alzheimer's disease. J Neural Transm (Vienna) (2004) 1.78
Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proc Natl Acad Sci U S A (2006) 1.73
Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A (1997) 1.73
Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology. J Neurochem (2009) 1.67
Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J Neuropathol Exp Neurol (1996) 1.67
Tau filaments from human brain and from in vitro assembly of recombinant protein show cross-beta structure. Proc Natl Acad Sci U S A (2003) 1.67
Conformational transformation and selection of synthetic prion strains. J Mol Biol (2011) 1.66
Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission. J Neurosci (2012) 1.63
Identification of an intracellular site of prion conversion. PLoS Pathog (2009) 1.61
Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions. J Neurochem (2010) 1.60
Retrovirus infection strongly enhances scrapie infectivity release in cell culture. EMBO J (2006) 1.53
Polar zippers: their role in human disease. Protein Sci (1994) 1.53
Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin. Hum Mol Genet (2006) 1.51
The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity. J Neurosci (2000) 1.51
Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. J Neurochem (2009) 1.50
Autophagy induction by trehalose counteracts cellular prion infection. Autophagy (2009) 1.46
A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7. Genet Res (1969) 1.45
Characterization of cytoplasmic alpha-synuclein aggregates. Fibril formation is tightly linked to the inclusion-forming process in cells. J Biol Chem (2002) 1.44
Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J Neurosci (2006) 1.43
Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis. J Biol Chem (2005) 1.42
Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis. Neurosci Lett (2007) 1.41
Interactome analyses identify ties of PrP and its mammalian paralogs to oligomannosidic N-glycans and endoplasmic reticulum-derived chaperones. PLoS Pathog (2009) 1.41
Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein. J Biol Chem (2006) 1.40
Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol Biol Cell (2000) 1.39
Mouse-adapted scrapie infection of SN56 cells: greater efficiency with microsome-associated versus purified PrP-res. J Virol (2006) 1.35
Globular domain of the prion protein needs to be unlocked by domain swapping to support prion protein conversion. J Biol Chem (2011) 1.29
The yeast Sup35NM domain propagates as a prion in mammalian cells. Proc Natl Acad Sci U S A (2008) 1.16
Cell line dependent RNA expression profiles of prion-infected mouse neuronal cells. J Mol Biol (2005) 1.08
Prion protein interaction with stress-inducible protein 1 enhances neuronal protein synthesis via mTOR. Proc Natl Acad Sci U S A (2010) 1.06
DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificity. Exp Biol Med (Maywood) (2006) 0.98
Prion-like propagation of cytosolic protein aggregates: insights from cell culture models. Prion (2009) 0.96
Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1. J Neurosci (2008) 0.96
Cellular aspects of prion replication in vitro. Viruses (2013) 0.95
Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein. J Biol Chem (2011) 0.94
Prion-induced activation of cholesterogenic gene expression by Srebp2 in neuronal cells. J Biol Chem (2009) 0.92
Inhibition of cholesterol recycling impairs cellular PrP(Sc) propagation. Cell Mol Life Sci (2009) 0.92
Tetracysteine-tagged prion protein allows discrimination between the native and converted forms. FEBS J (2010) 0.88
Prion infection influences murine endogenous retrovirus expression in neuronal cells. Biochem Biophys Res Commun (2006) 0.86
Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies. Mol Biotechnol (2006) 0.86
The novel sorting nexin SNX33 interferes with cellular PrP formation by modulation of PrP shedding. Traffic (2008) 0.86
Prion protein/protein interactions: fusion with yeast Sup35p-NM modulates cytosolic PrP aggregation in mammalian cells. FASEB J (2007) 0.84
Therapy in prion diseases: from molecular and cellular biology to therapeutic targets. Infect Disord Drug Targets (2009) 0.79
Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies. Methods Mol Biol (2004) 0.78
Dynamic interactions of Sup35p and PrP prion protein domains modulate aggregate nucleation and seeding. Prion (2009) 0.76
Effect of hydrophobic mutations in the H2-H3 subdomain of prion protein on stability and conversion in vitro and in vivo. PLoS One (2011) 0.76
Prion-induced and spontaneous formation of transmissible toxicity in PrP transgenic Drosophila. Biochem J (2014) 0.76
Identification of possible animal origins of prion disease in human beings. Lancet (2004) 0.75